FDA Approves Journavx Drug to Treat Pain Without Addiction Risk NYT Par : Gina Kolata 31 janvier 2025 à 01:12 The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. © Lucas Jackson/ReutersThe drug was tested in two large clinical trials, each with approximately 1,000 patients who had pain from surgery. In one, patients had an abdominoplasty, or tummy tuck; in the other, a bunionectomy.
Connexion
